Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 800
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 88%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

3SBio Inc., an investment holding company, develops, produces markets, and sells biopharmaceutical products in Mainland China and internationally. The company provides TPIAO, a recombinant human thrombopoietin to treat chemotherapy-induced thrombopenia and immune thrombocytopenia; and Cipterbin, an anti-HER2 monoclonal antibody for the treatment of advanced HER2-positive breast cancer and pan-HER2. It also offers Yisaipu, the receptor fusion tumor necrosis factor inhibitor; EPIAO and SEPO, an er...

Industry: Biotechnology
Sector: Healthcare
Address:
No. 3 A1, Road 10, Shenyang Economy and Tech. Development Zone, Shenyang, China
Latest News on TRSBF
No data available.